Procurement of Chemotherapy and Supportive Care Medications for AIIMS Gorakhpur

This tender, identified by Bid Number GEM/2026/B/7582550, is being issued by the All India Institute of Medical Sciences (AIIMS), Gorakhpur, under the Department of Health and Family Welfare, Ministry of Health and Family Welfare. The bid period commences on October 31, 2026, at 12:00 PM and concludes on November 02, 2026, at 1:00 PM. The tender seeks to procure a comprehensive range of injectable and oral chemotherapeutic agents, as well as supportive care medications. The extensive list of Item Categories includes, but is not limited to, Cyclophosphamide, Dacarbazine, Ifosfamide, Carboplatin, Oxaliplatin, Cisplatin, Epirubicin, Doxorubicin (including liposomal formulation), 5-Fluorouracil, Fludarabine, Gemcitabine, Pemetrexed, Methotrexate (injectable and tablet), Capecitabine, Paclitaxel (including albumin-bound), Docetaxel, Vincristine, Gefitinib, Imatinib, Rituximab, Trastuzumab, Zoledronic Acid, Bortezomib, Etoposide, Bevacizumab, Irinotecan, Bleomycin, Dactinomycin, Leucovorin, Filgrastim, Pegfilgrastim, Aprepitant, Fosaprepitant, Palonosetron, Leuprolide, Bicalutamide, Romiplostim, Abiraterone, and Enzalutamide. The total quantity required for these essential medications is 10,206 units. This procurement is critical for the Department of Health and Family Welfare to ensure the availability of vital cancer treatment drugs for patients served by AIIMS, Gorakhpur, located at 273008 All India Institute of Medical Sciences Kunraghat, Gorakhpur, Uttar Pradesh.